%PDF-1.3
%
1 0 obj
<>]/Pages 3 0 R/Type/Catalog/ViewerPreferences<>>>
endobj
2 0 obj
<>stream
uuid:2f1ef023-cdfc-6047-a2f5-f20230b8301e
adobe:docid:indd:6eea88a0-ac50-11e0-8096-aea4f2aba5f1
xmp.id:152bbc4e-0ab9-4754-92ff-8b07b1838273
proof:pdf
1
xmp.iid:f8e8a2c4-95de-4c5d-b6bc-dfb32d821d9a
xmp.did:73f441ce-e104-4ca1-b132-19ad8a1a6556
adobe:docid:indd:6eea88a0-ac50-11e0-8096-aea4f2aba5f1
default
converted
from application/x-indesign to application/pdf
Adobe InDesign 17.3 (Macintosh)
/
2022-11-15T19:26:50+01:00
2022-11-15T19:26:50+01:00
2022-11-15T19:26:51+01:00
2022-11-15T19:26:51+01:00
Adobe InDesign 17.3 (Macintosh)
application/pdf
WEB_25 mg_Erlotinib_PIL_V3.1, Stand Oktober 2022.indd
Adobe PDF Library 16.0.7
False
PDF/X-3:2002
PDF/X-3:2002
PDF/X-3:2002
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageTransformationMatrixList<0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<0 177>>/PageWidthList<0 445.039>>>>>>/Resources<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 445.039 1842.52]/Type/Page>>
endobj
7 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageTransformationMatrixList<0[1.0 0.0 0.0 1.0 0.0 0.0]>>/PageUIDList<0 5515>>/PageWidthList<0 445.039>>>>>>/Resources<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 445.039 1842.52]/Type/Page>>
endobj
16 0 obj
<>stream
HtWˮd
߯u>I=uYYqpTuہO]Q/>Ѯ>ׯ?Wo0